Comparison of Level of NKG2D Ligands between Normal and Tumor Tissue Using Multiplex RT-PCR

REFERENCES

• Parish C. R. Cancer immunotherapy: the past, the present and the future. Immunol. Cell Biol. 2003; 81(2)106–113
   PubMed Web of Science ®Google Scholar
• Offringa R., van der Burg S. H., Ossendorp F., Toes R. E., Melief C. J. Design and evaluation of antigen-specific vaccination strategies against cancer. Curr. Opin. Immunol. 2000; 12(5)576–582
   PubMed Web of Science ®Google Scholar
• Garrido F., Ruiz-Cabello F., Cabrera T., Perez-Villar J. J., Lopez-Botet M., Duggan-Keen M., Stern P. L. Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol. Today 1997; 18(2)89–95
   PubMedGoogle Scholar
• Karre K., Ljunggren H. G., Piontek G., Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986; 319(6055)675–678
   PubMed Web of Science ®Google Scholar
• Farag S. S., Fehniger T. A., Becknell B., Blaser B. W., Caligiuri M. A. New directions in natural killer cell-based immunotherapy of human cancer. Expert. Opin. Biol. Ther. 2003; 3(2)237–250
   PubMed Web of Science ®Google Scholar
• Moretta A., Bottino C., Vitale M., Pende D., Cantoni C., et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 2001; 19: 197–223
   PubMed Web of Science ®Google Scholar
• Malnati M. S., Lusso P., Ciccone E., Moretta A., Moretta L., Long E. O. Recognition of virus-infected cells by natural killer cell clones is controlled by polymorphic target cell elements. J. Exp. Med. 1993; 178(3)961–969
   PubMed Web of Science ®Google Scholar
• Routes J. M. IFN increases class I MHC antigen expression on adenovirus-infected human cells without inducing resistance to natural killer cell killing. J. Immunol. 1992; 149(7)2372–2377
   PubMed Web of Science ®Google Scholar
• Bauer S., Groh V., Wu J., Steinle A., Phillips J. H., Lanier L. L., Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999; 285(5428)727–729
   PubMed Web of Science ®Google Scholar
• Cosman D., Mullberg J., Sutherland C. L., Chin W., Armitage R., et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 2001; 14(2)123–133
   PubMed Web of Science ®Google Scholar
• Smyth M. J., Swann J., Cretney E., Zerafa N., Yokoyama W. M., Hayakawa Y. NKG2D function protects the host from tumor initiation. J. Exp. Med. 2005; 202(5)583–588
   PubMed Web of Science ®Google Scholar
• Vivier E., Tomasello E., Paul P. Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition?. Curr. Opin. Immunol. 2002; 14(3)306–311
   PubMed Web of Science ®Google Scholar
• Watzl C. The NKG2D receptor and its ligands-recognition beyond the “missing self”?. Microbes Infect. 2003; 5(1)31–37
   PubMed Web of Science ®Google Scholar
• Long E. O., Rajagopalan S. Stress signals activate natural killer cells. J. Exp. Med. 2002; 196(11)1399–1402
   PubMed Web of Science ®Google Scholar
• Rosenberg S. A., Lotze M. T., Muul L. M., Leitman S., Chang A. E., et al. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N. Engl. J. Med. 1985; 313(23)1485–1492
   PubMed Web of Science ®Google Scholar
• Gonzalez S., Groh V., Spies T. Immunobiology of human NKG2D and its ligands. Curr. Top. Microbiol. Immunol. 2006; 298: 121–138
   PubMed Web of Science ®Google Scholar
• Bahram S., Bresnahan M., Geraghty D. E., Spies T. A second lineage of mammalian major histocompatibility complex class I genes. Proc. Natl. Acad. Sci. USA 1994; 91(14)6259–6263
   PubMed Web of Science ®Google Scholar
• Groh V., Bahram S., Bauer S., Herman A., Beauchamp M., Spies T. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc. Natl. Acad. Sci. USA 1996; 93(22)12445–12450
   PubMed Web of Science ®Google Scholar
• Pende D., Rivera P., Marcenaro S., Chang C. C., Biassoni R., et al. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res. 2002; 62(21)6178–6186
   PubMed Web of Science ®Google Scholar
• Jinushi M., Takehara T., Tatsumi T., Kanto T., Groh V., et al. Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid. Int. J. Cancer. 2003; 104(3)354–361
   PubMed Web of Science ®Google Scholar
• Morikawa K., Walker S. M., Nakajima M., Pathak S., Jessup J. M., Fidler I. J. Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res. 1988; 48(23)6863–6871
   PubMed Web of Science ®Google Scholar
• Kaighn M. E., Narayan K. S., Ohnuki Y., Lechner J. F., Jones L. W. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest. Urol. 1979; 17(1)16–23
   PubMedGoogle Scholar
• Soule H. D., Vazguez J., Long A., Albert S., Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 1973; 51(5)1409–1416
   PubMed Web of Science ®Google Scholar
• Vickers P. J., Dickson R. B., Shoemaker R., Cowan K. H. A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone-independent tumor growth in vivo. Mol. Endocrinol. 1988; 2(10)886–892
   PubMed Web of Science ®Google Scholar
• Lee P. D., Sladek R., Greenwood C. M., Hudson T. J. Control genes and variability: absence of ubiquitous reference transcripts in diverse mammalian expression studies. Genome Res. 2002; 12(2)292–297
   PubMed Web of Science ®Google Scholar
• Welte S. A., Sinzger C., Lutz S. Z., Singh-Jasuja H., Sampaio K. L., et al. Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein. Eur. J. Immunol. 2003; 33(1)194–203
   PubMed Web of Science ®Google Scholar
• Higuchi R., Fockler C., Dollinger G., Watson R, Kinetic P CR. analysis: real-time monitoring of DNA amplification reactions. Biotechnology (NY). 1993; 11(9)1026–1030
   PubMedGoogle Scholar
• Klein D. Quantification using real-time PCR technology: applications and limitations. Trends Mol. Med. 2002; 8(6)257–260
   PubMed Web of Science ®Google Scholar
• Skrypina N. A., Timofeeva A. V., Khaspekov G. L., Savochkina L. P., Beabealashvilli R. Total RNA suitable for molecular biology analysis. J. Biotechnol. 2003; 105(1–2)1–9
   PubMed Web of Science ®Google Scholar
• Wagsater D., Dimberg J., Hugander A., Sirsjo A., Ghaderi M. Analysis of MICA gene transcripts in human rectal cancers. Anticancer Res. 2003; 23(3B)2525–2529
   PubMed Web of Science ®Google Scholar
• Pende D., Cantoni C., Rivera P., Vitale M., Castriconi R., et al. Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Eur. J. Immunol. 2001; 31(4)1076–1086
   PubMed Web of Science ®Google Scholar